Literature DB >> 1323363

Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects.

Y Zoukos1, T Thomaides, D V Pavitt, J P Leonard, M L Cuzner, C J Mathias.   

Abstract

Short term regulation of beta-adrenoceptors in peripheral blood mononuclear cells after sympathetic activation has been previously documented in normal individuals but changes after a central reduction in sympathetic activity are not known. We have studied beta-adrenoceptor number and affinity on peripheral blood mononuclear cells in normal subjects, before and after intravenous clonidine, an alpha 2-adrenoceptor agonist which lowers blood pressure predominantly by reducing central nervous system sympathetic outflow. After clonidine there was a decrease in plasma levels of noradrenaline and adrenaline, and an increase in growth hormone. There was up-regulation of beta-adrenergic receptors on peripheral blood mononuclear cells 30 and 60 min after clonidine which was related to the fall in blood pressure, noradrenaline and adrenaline levels and to the increase in growth hormone levels. The affinity of the receptors was decreased. Return to baseline values was observed after 2 h. Intracellular production of cAMP after isoproterenol stimulation demonstrated that the up-regulation was not functional. Our studies indicate short term up-regulation of beta-adrenoceptors in peripheral blood mononuclear cells after clonidine. These observations after a reduction in sympathetic activity may be of importance if they mirror the pattern of redistribution of adrenoceptors, which are present in a wide range of tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323363     DOI: 10.1007/bf01818957

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  25 in total

1.  Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.

Authors:  A H van den Meiracker; A J Man in't Veld; F Boomsma; D J Fischberg; P B Molinoff; M A Schalekamp
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 3.  Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors.

Authors:  R J Lefkowitz; M G Caron; G L Stiles
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

4.  Beta-adrenoceptor adaptation to acute exercise.

Authors:  J Butler; J G Kelly; K O'Malley; F Pidgeon
Journal:  J Physiol       Date:  1983-11       Impact factor: 5.182

5.  Effect of clonidine on growth hormone and glucagon secretion.

Authors:  S Lal; G Tolis; T J McDonald; P Cervantes; J Dupré
Journal:  Horm Metab Res       Date:  1981-11       Impact factor: 2.936

6.  In vivo regulation of beta-adrenergic receptors on human mononuclear leukocytes: assessment of receptor number, location, and function after posture change, exercise, and isoproterenol infusion.

Authors:  A DeBlasi; A S Maisel; R D Feldman; M G Ziegler; M Fratelli; M DiLallo; D A Smith; C Y Lai; H J Motulsky
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

7.  Identical binding properties of (+/-)- and (-)-125Iodocyanopindolol to beta 2-adrenoceptors in intact human lymphocytes.

Authors:  N O'Hara; O E Brodde
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-11

8.  beta-Receptor numbers and thermodynamics in denervation supersensitivity.

Authors:  R Bannister; A W Boylston; I B Davies; C J Mathias; P S Sever; D Sudera
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

9.  Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans.

Authors:  S B Liggett; J C Marker; S D Shah; C L Roper; P E Cryer
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number.

Authors:  J F Tohmeh; P E Cryer
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

View more
  5 in total

Review 1.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

2.  Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis.

Authors:  Mario Habek; Luka Crnošija; Mila Lovrić; Anamari Junaković; Magdalena Krbot Skorić; Ivan Adamec
Journal:  Clin Auton Res       Date:  2016-07-22       Impact factor: 4.435

3.  Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose.

Authors:  C Magnan; S Collins; M F Berthault; N Kassis; M Vincent; M Gilbert; L Pénicaud; A Ktorza; F Assimacopoulos-Jeannet
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

4.  Clinical Practice: Should we Radically Alter our Sedation of Critical Care Patients, Especially Given the COVID-19 Pandemics?

Authors:  D Longrois; F Petitjeans; O Simonet; M de Kock; M Belliveau; C Pichot; Th Lieutaud; M Ghignone; L Quintin
Journal:  Rom J Anaesth Intensive Care       Date:  2021-01-04

5.  Tyrosine hydroxylase and β2-adrenergic receptor expression in leukocytes of spontaneously hypertensive rats: putative peripheral markers of central sympathetic activity.

Authors:  L M Nisimura; P Bousquet; F Muccillo; E Tibirica; L R Garzoni
Journal:  Braz J Med Biol Res       Date:  2020-10-30       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.